Economics

Geez, I’m kind of overwhelmed by all the data for The Report. The life science sector is so big and complex. There’s no end to the information. I’ve had to say, “Enough!” to myself just to get started. Also the importance of the market-driven sector in cancer management keeps growing in my mind. I think this is key to anyone ...

Best practices articel from onPhilanthropy asks the question: Is your donor base as diverse as the population you serve: Some quotes:

Having gushed effusively about Leroy Hood, I’d like to turn to the China part of the conference. First, through, one last note about Hood. He had three messages for the Chinese: Everything he’s ever done that was important (including current work) has been met with great resistance. It’s not too late to get in on the ground floor of systems ...

One of the most interesting aspects of this conference on molecular medicine was a couple of sessions about intellectual property (IP). IP is the mother’s milk of the life science industry. What they have that is really of value is what they know and know how to do. Those intangibles are the gold assets of the industry just as the ...